Breast Diseases  >>  Ogsiveo (nirogacestat)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Ogsiveo (nirogacestat) / SpringWorks Therap
NCT01876251: A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast Cancer

Checkmark ASCO 2015
May 2015 - May 2015: ASCO 2015
Terminated
1b
30
US, Europe
PF-03084014, Docetaxel, Taxotere
Pfizer
Breast Cancer Metastatic
12/15
12/15

Download Options